Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang

Chinese Journal of Pathology

Volumn 36, Issue 8, 2007, Pages 511-515

  Zheng, Xing Zheng ^a   Yang, An Qiang ^a   Pan, Xiao Lin ^a   Zheng, Li Li ^a   Zhou, Qiu Yuan ^a   Li, Xin Min ^a   Wang, Xiao Ling ^a   Yan, Li Hua ^a   Li, Hong An ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Cervix neoplasms; Gene, p53; Papillomavirus, human; Polymorphism, restriction fragment length

Indexed keywords

PROTEIN P53;

ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADULT; AGED; ALLELES; BASE SEQUENCE; CHINA; CODON; DNA, NEOPLASM; EXONS; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 34848879201     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chinese source
2. Chinese source
3. Chinese source
4. Chou RH, Huang H. Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite. Biochem Biophys Res Commun, 2002, 293(1): 298-306.
5. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998, 393(6682): 229-234.
6. Zehbe I, Voglino G, Wilander E, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res, 2001, 61(2): 608-611.
7. Dokianakis DN, Spandidos DA. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol Cell Biol Res Commun, 2000, 3(2): 111-114.
8. Szarka K, Veress G, Juhasz A, et al. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers. Anticancer Res, 2000, 20(3B): 2161-2167.
9. Chinese source
10. Ngan HY, Liu VW, Liu SS, et al. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer, 1999, 80(11): 1828-1829.
11. Yamashita T, Yaginuma Y, Saitoh Y, et al. Codon72 polymorphism of P53 as a risk factor for patients with human papillomavirus-associated squamous inraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis, 1999, 20 (9): 1733-1736.
12. Bhattacharya P, Duttagupta C, Sengupta S. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Lett, 2002, 188(1-2): 207-211.
13. Tong D, Kucera E, Stimpfl M, et al. Detection of p53 polymorphism at codon 72 by PCR and allele-specific oligonucleotide hybridization on microtiter plates. Clin Chem, 2000, 46(1): 124-126.
14. Lukaszuk K, Liss J, Wozniak I, et al. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J Clin Microbiol, 2003, 41(2): 608-612.
15. Thomas MC, Chiang CM. E6 oncoprotein represses p53-dependent gene activation via Inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell, 2005, 17(2): 251-264.
16. Siddique M, Sabapathy K. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene, 2006, 25(25): 3489-3500.
17. Dumont P, Leu JI, Della Pietra AC 3rd, et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 2003, 33(3): 357-365.
18. Bergamaschi D, Samuels Y, Sullivan A, et al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorpHic p53. Nat Genet, 2006, 38(10): 1133-1141.
19. Schneider-Stock R, Mawrin C, Motsch C, et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol, 2004, 164(4): 1233-1241.
20. Tada M, Furuuchi K, Kaneda M, et al. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants. Carcinogenesis, 2001, 22(3): 515-517.